大行評級|里昂:上調美團目標價至225港元 預計第三季經調整Ebit同比大增141%
里昂發表報吿,預計美團第三季總營收按年穩健增長20%至918億元,經調整Ebit較去年同期上升141%至120億元。由於訂單增加,食品外送收入應可按年增長14%,而到店、酒店及旅遊收入可能按年增長23%,主要由於總交易額增加所致。該行預計,美團第三季核心商務的經調整EBIT較去年同期上升37%至138億元,食品外送利潤率創新高,店內利潤率回升。新業務虧損可能按年收窄65%至18億元,並預期此趨勢將於第四季延續。里昂上調美團2025及2026年淨利潤預測各2%和3%,目標價由182港元上調至225港元,維持“跑贏大市”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.